Pharmacological inhibition in the ataxia telangiectasia and Rad3-linked protein serine/threonine kinase (ATR; often known as FRAP-connected protein (FRP1)) has emerged as being a promising approach for cancer treatment that exploits artificial lethal interactions with proteins linked to DNA problems mend, overcomes resistance to other therapies and boosts antitumour immunity. Several https://lordm777bnx0.blogproducer.com/profile